VGH-TPE Microbiology Culture Report Amikacin Ampicillin Aztreonam Cefazolin Cefoperazone Cefotaxime/Ceftizoxime Ceftazidime Cefuroxime Ceftriaxone Chloramphenicol Clindamycin

Erythromycin Gentamicin Metronidazole Flomoxef Ciprofloxacin Cefepime Oxacillin Penicillin-G Tetracycline/Minocycline Piperacillin/Tazobactam Tobramycin/Netilmicin Trimethoprim-sulfamethoxazole Vancomycin Teicoplanin Imipenem GI, Liver SBP

Amikin Azactam Tydine/Cephalexin/Keflex CPZ Claforan/Epocelin Fortum Zinnet/Zinacef Rocephin Cleocin Rulid Gentamycin Anegyn Flumarin Ciproxin Maxipime Prostaphlin

Tazocin Aminoglycosides Bactar/Bacide/Bactrim

Tienam

K.P. Ampicillin resistant Cephalosporins Cefazolin 1gm IV Q6H MIC kidney renal function minimum 100mg Q8H Impaired renal function 1. Aminoglycosides 2. G(-) infectionrenal function 2nd Cephalosporins Cr1.5 Cr 1.52.0 frequencyQ8HQ12HQD Cr 2.02.5 3.0gm2.0gm Cr 2.53.0 frequency 2nd Cephalosporins cover 1. H. influenza 2. G(+) G(-) 3. COPD infection 4. Acinetobacter s.p. Acinetobacter baumanii G(+) G(-) for mixed infection

 2nd Cephalosporins 1.Cefuroxime 2.AugmentinAmoxicillinClavulanate 3.UnasynAmpicillinSulbactam 4.Cefmetazole 5.Pefloxacin 6.Tobramycin Cefuroxime Tobramycin NS Cefmetazole Cephamycins Cephalosporins 2nd Cephalosporins cover Anaerobic Augmentin Cefuroxime kidney 1gm Q6H 2gm Q8H Side effectbleeding tendency Anaerobics ClindamycinCleocin MetronidazoleAnegyn Cephamycins monotherapy Augmentin -lactam Mixed infections Anaerobics monotherapy cover G(+) Clindamycin Diaphragm Augmentin Metronidazole Diaphragm Cefmetazole Clindamycin -lactam cover diaphragm Bacteroides fragilis liver Maximum dose 600mg Q8H Pseudomonas colitis Antibioticassociated diarrhea diaphragm Anaerobic infection Augmentin MetronidazoleAnegyn/Flagyl cover diaphragm Bacteroides fragilis diaphragm AnaerobicsClostridium difficile Anaerobics Meropenem Anaerobics oral form parasites liver 500mg/1 Bag Q6h Side effect Peripheral neuropathy indications 1.PMC Pseudomembranous colitis polyp colon lesionDrug of choice Metronidazole 2.Suppurative thrombophlebitis Bacteroides 1gm Q8H 1.52 Pefloxacin 2nd Cephalosporins Quinolones ProstateQuinolones Baktar Prostatitis indicated liver kidney Cr2.0 400mg Q12HCr2.0 200mg Q12H Side effectNausea/Vomitingappetite

Syphilis VDRL positive1:dl negative1+2+ positive positive TPHA FTA-ABS marker specific Neurosyphilis CSF cell count CNS 3gm Q4H 2gm Q6H Endocarditis 2gm Q4H Osteomyelitis 2gm Q4H Dose renal function seizure Penicillin Chloramphenicol Bone marrow suppression pancytopenia ImipenemMeropenem broad Salmonella 1.Ampicillin 2.BactarTMP-SMX 3.Chloramphenical 4.RocephinCeftriaxone 5.QuinolonesCiprofloxacinPefloxacin Salmonella spp. resistance Fortum Ceftazidime Pseudomonas aeruginosa UnasynAmpicillin 1gmSulbactamMaxtam500mgQ8H Ampicillin -lactam Sulbactam -lactamase inhibitor Aminoglycosides CefoperazoneCPZSulbactam CeftazidimeFortumSulbactam Aminoglycosides GNBE. coliK.P. Comments Dosage Gentamycin 60mg Q8H 1st Cephalosporins Tobramycin 80mg Q8H Gentamycin resistance Amikacin 500mg Q12H resistance GM Sisomicin 100mg Q12H 3rd Cephalosporins Netilmycin 500mg Q12H GS Exacin 400mg QD/200mg Q12H Post-antibiotic effect Amikacin Serum antibiotics GNBTrough level/Once daily dosing Aminoglycosides cover Pseudomonas Pseudomonas urine Pseudomonas renal function Fosfomycin

 Others group Kinfomycincover G(+) G(-) synergic effectG(+)G(-) G(+) VancomycinFosfomycin MRSA TeicoplaninFosfomycin kidney renal toxicity IndicationsKidney function Maximum 2gm Q12H 1gm Q12H 3rd Cephalosporins indications (1) Intensive SepsisNo time to wait (2) Culture ResultNo response to 2nd Cephalosporins (3) Combined Infections cover (4) Allergy (5) VIP 3rd Cephalosporinscover G(-) CefotaximeClaforan/CeftizoximeEpocelinCefoperazo M I neCPZ/PiperacillinPipril Immun C e CeftriaxoneRocephin/Flomoxef CeftazidimeFortum/AztreonamAzactam CefepimeMaxipime/Cefpirome Ofloxacin/Ciprofloxacin Imipenem/Meropenem Cephalosporins cover Pseudomonas aeruginosa Pseudomonas aeruginosa ClaforanEpocelinRocephinFlomoxef ABX BBB Cephalosporins CPZ Clindamycin BBB Bacterial Meningitis PenicillinRocephin Bacterial MeningitisGolden standard AmpicillinClaforan TimentinTicarcillinClavulanate 2nd 3rd Ticarcillin -lactamase inhibitor 2nd 3rd cover G(+)G(-) Anaerobic MIC Broad-spectrum kidney Maximum 3.2gm Q6H OncologyHematology Chemotherapy Neutropenic fever Prophylaxis for neutropenic feverTimentinCefoperazoneTazocinPiperacillin CefotaximeClaforan Cephalosporins Cephalosporins Cover cover GNB K.P. E. coli Pseudomonas Cephalosporins G(+) cover toxic Community-acquired pneumonia SBP

 liver half-life Dosage 2gm Q6H CeftizoximeEpocelin Claforan Anaerobic propa liver Dosage 2gm Q8H PiperacillinPipril Extended-Spectrum Penicillin Pfizer Half-life cover Salmonella Pseudomonas Anaerobics effect 2gm QD 2gm Q12H K.P. Endophthalmitis first choice Gonorrhea 2gm STAT CefoperazoneCPZCefobid Anti-Pseudomonas effect80% Pseudomonas GNB Anaerobic liver kidney Liver Half-life Maximum dose 2gm Q6-8H Osteomyelitis/Meningitis/Endocarditis 2gm Q4H 4gm Q6H side effect cost FlomoxefFlumarin Moxalactam Bleeding tendency G(+) Cover AnaerobicGNB Anti-Pseudomonas effect ESBL first choice Tazocin Kidney Dosage 2gm Q8H CeftazidimeFortum/AztreonamAzactam Cephalosporins FortumCeftazidime Psedomonas aeruginosa Basics G(+) GNBABPseudomonas G(-) Kidney 2gm Q8H AztreonamAzactamER Fortum 700 Easy infection Kidney 1gm Q6HSevere 2gm Q8H Cephalosporins Cefepime Cefpirome AventisEasy infection 2gm Q12H cover G(+) No AnaerobicNo MRSANo enterococcus effect cover G(-) Fortum resistance Kidney Dosage 2gm Q8H

TazocinPiperacillin+Tazobactam Mixed Infection ESBL Antibiotics cover Anaerobics Propa Neutropenic fever Tazocin 2.25gmDosage 4.5gm Q6H 3.375gm Q8H MaxtamCPZ Anti-pseudomonas effect Penicillin Anaerobics effect TazocinTimentin Ofloxacin/LevofloxacinCravit Ofloxacin Quinolones Chlamydia trachomatis STD Pseudomonas Ciprofloxacin Dosage 400mg Q12H renal impairment Levofloxacin Ofloxacin cover Pneumococci QD Ciprofloxacin Quinolones concentration-dependent Post-antibiotic effect Kidney Dosage 400mg Q12H Ciprofloxacin Quinolones BBB Ciprofloxacin cover 1.GNB Imipenem 2.G(+) Anthrax 3.Salmonella 4.TB AIDS Atypical TB 5.Legionella 6.Atypical pneumonia Quinolones virus Antibiotics resistance Imipenem+CilastatinTienamMaximum dose 2gm QD 500mg Q6H Imipenem solve Cilastatin In vitro In vivo BBB side effect Convulsion MeropenemMepem1gm Q8H Anaerobic cover MIC Carbapenem BBB G(+)G(-) cover Anaerobic AB ICUs V.S. Ventilator 2G(+) & G(-) 1. MRSA G(+) 2. Enterococcus G(+) 3. Stenotrophomonas maltophilia G(-) 4. Burkholderia cepcia G(-) G(-) Imipenem Vancomycin/Teicoplanin Glycopeptides indication MRSA Clostridium difficile G(-) 80% G(+) MRSA MRSA Teicoplainin Vancomycin Pharmacogenetics(?) response

Vancomycin liver liver toxicity CNS infection Maximum Dose 500mg Q6H 1gm Q12H Vancomycin Post-Antibiotics effect Side effect Red Man Syndrome/Skin allergy infusion rate dosage interval Antihistamine Bone marrow suppression monitor serum drug level renal function serum drug level DigoxinTheophyllin renal toxicity Aminoglycosides reversible Teicoplainin Allergy monitor drug level renal function Dosage 400mg Q12H X 3 doses Vancomycin liver toxicity Teicoplainin Half-life Drug fever 400mg QD Side effect Teicoplainin Chronic osteomyelitis MRSA Clindamycin/BACTAR cover MRSA/Vancomycin/Teicoplainin CefmetazoleFosfomycin MSSAMethicillin Sensitive Staphylococcus aureusV.S. MRSA BaktarTrimethoprim-sulfamethoxazole Steven Johnson Syndrome Bone marrow suppression Kidney IV Enterococcus Salmonella Oral form IV form form MRSA cover Anaerobic 2 vial Q6H HIV carrier PCP Gas 4 vial Q6H dramatic Baktar Viral infection Serology identify effective Herpes infection CNS CNS infection conscious change Bizarre behavior virus Parenchyma Viral encephalitis AcyclovirCMV IVIG EnterovirusEBVCMVHSV